Kwok W, Lung D, Tam T, Yap D, Ma T, Tsui C
Vaccines (Basel). 2024; 12(7).
PMID: 39066342
PMC: 11281690.
DOI: 10.3390/vaccines12070704.
Kanakan A, Kumar A, Kaur U, Narwade P, Rain Z, Yadav N
Am J Trop Med Hyg. 2023; 109(5):1137-1140.
PMID: 37696514
PMC: 10622473.
DOI: 10.4269/ajtmh.23-0284.
Christenson S
Respir Care. 2023; 68(7):871-880.
PMID: 37353326
PMC: 10289620.
DOI: 10.4187/respcare.11035.
Alsayed A, Abed A, Khader H, Al-Shdifat L, Hasoun L, Al-Rshaidat M
Int J Mol Sci. 2023; 24(4).
PMID: 36835503
PMC: 9966333.
DOI: 10.3390/ijms24044086.
Ullah M, Malamardi S, Siddaiah J, A T, Prashant A, Vishwanath P
Antibiotics (Basel). 2022; 11(11).
PMID: 36358232
PMC: 9686600.
DOI: 10.3390/antibiotics11111577.
Effects of repeated infections with non-typeable Haemophilus influenzae on lung in vitamin D deficient and smoking mice.
Serre J, Tanjeko A, Mathyssen C, Heigl T, Sacreas A, Cook D
Respir Res. 2022; 23(1):40.
PMID: 35236342
PMC: 8889723.
DOI: 10.1186/s12931-022-01962-6.
Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis in community-acquired pneumonia.
Waagsbo B, Buset E, Longva J, Bjerke M, Bakkene B, Ertesvag A
BMC Infect Dis. 2022; 22(1):203.
PMID: 35236305
PMC: 8889388.
DOI: 10.1186/s12879-022-07199-4.
Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study.
Yang M, Liu X, Hu Q, Li J, Fu S, Chen D
BMJ Open. 2022; 12(1):e051939.
PMID: 35058259
PMC: 8783821.
DOI: 10.1136/bmjopen-2021-051939.
The lung microbiome: progress and promise.
Whiteside S, McGinniss J, Collman R
J Clin Invest. 2021; 131(15).
PMID: 34338230
PMC: 8321564.
DOI: 10.1172/JCI150473.
Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis.
Spies R, Potter M, Hollamby R, van der Walt S, Hohlfeld A, Ochodo E
Syst Rev. 2021; 10(1):211.
PMID: 34315541
PMC: 8317370.
DOI: 10.1186/s13643-021-01767-6.
Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV.
Cane J, Tregidgo L, Thulborn S, Finch D, Bafadhel M
Int J Chron Obstruct Pulmon Dis. 2021; 16:1437-1447.
PMID: 34093009
PMC: 8170372.
DOI: 10.2147/COPD.S301622.
Keratan sulfate-based glycomimetics using Langerin as a target for COPD: lessons from studies on Fut8 and core fucose.
Ohkawa Y, Harada Y, Taniguchi N
Biochem Soc Trans. 2021; 49(1):441-453.
PMID: 33616615
PMC: 7924997.
DOI: 10.1042/BST20200780.
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
Janjua S, Mathioudakis A, Fortescue R, Walker R, Sharif S, Threapleton C
Cochrane Database Syst Rev. 2021; 1:CD013198.
PMID: 33448349
PMC: 8092479.
DOI: 10.1002/14651858.CD013198.pub2.
Chronic Obstructive Pulmonary Disease: Inpatient Management.
Harte B, Wesorick D, Odden A
Hosp Med Clin. 2020; 2(2):e169-e191.
PMID: 32288997
PMC: 7104036.
DOI: 10.1016/j.ehmc.2012.12.001.
Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis.
Stolbrink M, Bonnett L, Blakey J
BMJ Open Respir Res. 2019; 6(1):e000458.
PMID: 31681477
PMC: 6797433.
DOI: 10.1136/bmjresp-2019-000458.
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Moghoofei M, Azimzadeh Jamalkandi S, Moein M, Salimian J, Ahmadi A
Infection. 2019; 48(1):19-35.
PMID: 31482316
DOI: 10.1007/s15010-019-01350-1.
Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.
Threapleton C, Janjua S, Fortescue R, Baker E
Cochrane Database Syst Rev. 2019; 5:CD013024.
PMID: 31125127
PMC: 6534184.
DOI: 10.1002/14651858.CD013024.pub2.
Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.
Gimenez M, Aguilar L, Granizo J
Multidiscip Respir Med. 2018; 13:40.
PMID: 30410757
PMC: 6214181.
DOI: 10.1186/s40248-018-0152-5.
The Lung Microbiome and Its Role in Pneumonia.
Wu B, Segal L
Clin Chest Med. 2018; 39(4):677-689.
PMID: 30390741
PMC: 6221463.
DOI: 10.1016/j.ccm.2018.07.003.
Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider D, Frei A, Steurer-Stey C, Garcia-Aymerich J, Puhan M
Cochrane Database Syst Rev. 2018; 10:CD010257.
PMID: 30371937
PMC: 6517133.
DOI: 10.1002/14651858.CD010257.pub2.